CryoPort

IPO

Homepage - Cryoport, Inc

Public · Nashville, United States · Founded 2005 · $326.0M raised

Employees
501–1000
Founded
2005
Business Model
B2B
Total Funding
$326.0M
Last Round
$51.0M Series CFeb 2021
Rounds
2
Type
Public

About

Cryoport, Inc. (Nasdaq: CYRX) is a global leader in temperature-controlled supply chain solutions for the life sciences industry, serving the biopharma, animal health, and reproductive medicine markets. The company operates through three subsidiaries — Cryoport Systems, MVE Biological Solutions, and CRYOGENE — with 50 strategic locations across the Americas, EMEA, and APAC. As the world's largest manufacturer of cryogenic systems, Cryoport provides bio-logistics, bio-storage, bio-processing, and cryogenic solutions critical to cell and gene therapies.

Summary

CryoPort is a Biotech company based in Nashville, United States, founded in 2005. It has raised $326.0M in total across 2 rounds, most recently a $51.0M Series C round in Feb 2021. Investors include Blackstone.

Tech & App Stack

5 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series CSeries CFeb 2021
$51.0M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies